Lipid Nanoparticles-Based Therapy in Liver Metastasis Management: From Tumor Cell-Directed Strategy to Liver Microenvironment-Directed Strategy

Overview

Journal Int J Nanomedicine

Publisher Dove Medical Press

Specialty Biotechnology

Date 2023 Jun 8

PMID 37288351

Authors

Yuhan Wang

Zhenyu Yin

Lei Gao

Bin Ma

Jianming Shi

Hao Chen

Affiliations

Soon will be listed here.

Abstract

Metastasis to the liver, as one of the most frequent metastatic patterns, was associated with poor prognosis. Major drawbacks of conventional therapies in liver metastasis were the lack of metastatic-targeting ability, predominant systemic toxicities and incapability of tumor microenvironment modulations. Lipid nanoparticles-based strategies like galactosylated, lyso-thermosensitive or active-targeting chemotherapeutics liposomes have been explored in liver metastasis management. This review aimed to summarize the state-of-art lipid nanoparticles-based therapies in liver metastasis management. Clinical and translational studies on the lipid nanoparticles in treating liver metastasis were searched up to April, 2023 from online databases. This review focused not only on the updates in drug-encapsulated lipid nanoparticles directly targeting metastatic cancer cells in treating liver metastasis, but more importantly on research frontiers in drug-loading lipid nanoparticles targeting nonparenchymal liver tumor microenvironment components in treating liver metastasis, which showed promise for future clinical oncological practice.

Citing Articles

Nanotechnology for the Diagnosis and Treatment of Liver Cancer.

Cai Y, Wang W, Jiao Q, Hu T, Ren Y, Su X Int J Nanomedicine. 2024; 19:13805-13821.

PMID: 39735328 PMC: 11681781. DOI: 10.2147/IJN.S490661.

Preliminary Study on Pharmacokinetics and Antitumor Pharmacodynamics of Folic Acid Modified Crebanine Polyethyleneglycol-Polylactic Acid Hydroxyacetic Acid Copolymer Nanoparticles.

Cheng X, Pan R, Tang J, Yu K, Zhang H, Zhao X Int J Nanomedicine. 2024; 19:10513-10536.

PMID: 39435040 PMC: 11492913. DOI: 10.2147/IJN.S477027.

Natural biomimetic nano-system for drug delivery in the treatment of rheumatoid arthritis: a literature review of the last 5 years.

Li J, Li W, Zhuang L Front Med (Lausanne). 2024; 11:1385123.

PMID: 38784236 PMC: 11114446. DOI: 10.3389/fmed.2024.1385123.

References

Rosales-Perez K, Elizalde-Velazquez G, Gomez-Olivan L, Orozco-Hernandez J, Cardoso-Vera J, Heredia-Garcia G . Response to letter to the editor about Rosales-Pérez et al., 2022 (https://doi.org/10.1016/j.chemosphere.2022.133791)instigating reflections on methodological and analytical rigor in ecotoxicological studies based on the research by Rosales-Pérez et.... Chemosphere. 2022; 312(Pt 1):137128. DOI: 10.1016/j.chemosphere.2022.137128. View

Zuo Y, Ren S, Wang M, Liu B, Yang J, Kuai X . Novel roles of liver sinusoidal endothelial cell lectin in colon carcinoma cell adhesion, migration and in-vivo metastasis to the liver. Gut. 2012; 62(8):1169-78. DOI: 10.1136/gutjnl-2011-300593. View

Menilli L, Milani C, Reddi E, Moret F . Overview of Nanoparticle-Based Approaches for the Combination of Photodynamic Therapy (PDT) and Chemotherapy at the Preclinical Stage. Cancers (Basel). 2022; 14(18). PMC: 9496990. DOI: 10.3390/cancers14184462. View

Pan Y, He Y, Zhao X, Pan Y, Meng X, Lv Z . Engineered Red Blood Cell Membrane-Coating Salidroside/Indocyanine Green Nanovesicles for High-Efficiency Hypoxic Targeting Phototherapy of Triple-Negative Breast Cancer. Adv Healthc Mater. 2022; 11(17):e2200962. DOI: 10.1002/adhm.202200962. View

Chang Y, Hsu W, Chang C, Lan K, Ting G, Lee T . Combined therapeutic efficacy of Re-liposomes and sorafenib in an experimental colorectal cancer liver metastasis model by intrasplenic injection of C26- murine colon cancer cells. Mol Clin Oncol. 2014; 2(3):380-384. PMC: 3999117. DOI: 10.3892/mco.2014.246. View

Campbell F, Bos F, Sieber S, Arias-Alpizar G, Koch B, Huwyler J . Directing Nanoparticle Biodistribution through Evasion and Exploitation of Stab2-Dependent Nanoparticle Uptake. ACS Nano. 2018; 12(3):2138-2150. PMC: 5876619. DOI: 10.1021/acsnano.7b06995. View

Liao R, Zhang X, Li G, Qin K, Yan X . Comparison of transcatheter arterial chemoembolization with raltitrexed plus liposomal doxorubicin tegafur plus pirarubicin for unresectable hepatocellular carcinoma. J Gastrointest Oncol. 2020; 11(4):747-759. PMC: 7475337. DOI: 10.21037/jgo-20-59. View

Pohlen U, Reszka R, Buhr H, Berger G . Hepatic arterial infusion in the treatment of liver metastases with PEG liposomes in combination with degradable starch microspheres (DSM) increases tumor 5-FU concentration. an animal study in CC-531 liver tumor-bearing rats. Anticancer Res. 2011; 31(1):147-52. View

Ozdemir A, Simay Demir Y, Yesilyurt Z, Ark M . Senescent cells and SASP in cancer microenvironment: New approaches in cancer therapy. Adv Protein Chem Struct Biol. 2023; 133:115-158. DOI: 10.1016/bs.apcsb.2022.10.002. View

10.

Kalra A, Kim J, Klinz S, Paz N, Cain J, Drummond D . Preclinical activity of nanoliposomal irinotecan is governed by tumor deposition and intratumor prodrug conversion. Cancer Res. 2014; 74(23):7003-13. DOI: 10.1158/0008-5472.CAN-14-0572. View

11.

Wang J, Li S, Liu Y, Zhang C, Li H, Lai B . Metastatic patterns and survival outcomes in patients with stage IV colon cancer: A population-based analysis. Cancer Med. 2019; 9(1):361-373. PMC: 6943094. DOI: 10.1002/cam4.2673. View

12.

Wei-Ze L, Wen-Xia H, Ning Z, Shu-Miao H, Fei L, Li-Na F . A novel embolic microspheres with micro nano binary progressive structure for transarterial chemoembolization applications. Eur J Pharm Sci. 2020; 153:105496. DOI: 10.1016/j.ejps.2020.105496. View

13.

Trefts E, Gannon M, Wasserman D . The liver. Curr Biol. 2017; 27(21):R1147-R1151. PMC: 5897118. DOI: 10.1016/j.cub.2017.09.019. View

14.

Argyriou A, Cavaletti G, Briani C, Velasco R, Bruna J, Campagnolo M . Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer. Cancer. 2012; 119(2):438-44. DOI: 10.1002/cncr.27732. View

15.

Budczies J, von Winterfeld M, Klauschen F, Bockmayr M, Lennerz J, Denkert C . The landscape of metastatic progression patterns across major human cancers. Oncotarget. 2014; 6(1):570-83. PMC: 4381616. DOI: 10.18632/oncotarget.2677. View

16.

Nordlinger B, Sorbye H, Glimelius B, Poston G, Schlag P, Rougier P . Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2013; 14(12):1208-15. DOI: 10.1016/S1470-2045(13)70447-9. View

17.

Kaps L, Schuppan D . Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using Nanocarriers. Cells. 2020; 9(9). PMC: 7563527. DOI: 10.3390/cells9092027. View

18.

Sabbadin C, Bordin L, Dona G, Manso J, Avruscio G, Armanini D . Licorice: From Pseudohyperaldosteronism to Therapeutic Uses. Front Endocrinol (Lausanne). 2019; 10:484. PMC: 6657287. DOI: 10.3389/fendo.2019.00484. View

19.

Wilkinson A, Qurashi M, Shetty S . The Role of Sinusoidal Endothelial Cells in the Axis of Inflammation and Cancer Within the Liver. Front Physiol. 2020; 11:990. PMC: 7485256. DOI: 10.3389/fphys.2020.00990. View

20.

Ma S, Zhou J, Zhang Y, Yang B, He Y, Tian C . An Oxygen Self-sufficient Fluorinated Nanoplatform for Relieved Tumor Hypoxia and Enhanced Photodynamic Therapy of Cancers. ACS Appl Mater Interfaces. 2019; 11(8):7731-7742. DOI: 10.1021/acsami.8b19840. View